A new NF-κB inhibitor attenuates a TH1 type immune response in a murine model

FEBS Letters

Volumn 578, Issue 1-2, 2004, Pages 36-40

  Kabashima, Kenji ^a   Honda, Tetsuya ^a   Nunokawa, Youichi ^b   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Delayed type hypersensitivity; Dendritic cell; DTH, delayed type hypersensitivity; Inhibitor; NF B, nuclear factor kappa B; Nuclear factor kappa B; OVA, ovalbumin; T cell; TH1; UV, ultraviolet

Indexed keywords

CYTOKINE; DSKB 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; OVALBUMIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; DSKB 2 COMPOUND; DSKB-2 COMPOUND; INDAN; INDAN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE; TH1 CELL; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; RADIATION EXPOSURE; SKIN; ULTRAVIOLET RADIATION;

MURINAE;

ANIMALS; CELL LINE; DENDRITIC CELLS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INDANS; INFLAMMATION; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NF-KAPPA B; SKIN; TH1 CELLS; ULTRAVIOLET RAYS;

EID: 9644294616     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.10.065     Document Type: Article

References (23)

1. Ghosh S., May M.J., Kopp E.B. Annu. Rev. Immunol. 16:1998;225-260
2. Karin M., Ben-Neriah Y. Annu. Rev. Immunol. 18:2000;621-663
3. Caamano J., Hunter C.A. Clin. Microbiol. Rev. 15:2002;414-429
4. Li Q., Verma I.M. Nat. Rev. Immunol. 2:2002;725-734
5. Yamamoto Y., Gaynor R.B. J. Clin. Invest. 107:2001;135-142
6. Epinat J.C., Gilmore T.D. Oncogene. 18:1999;6896-6909
7. Nakamura H., Aoki M., Tamai K., Oishi M., Ogihara T., Kaneda Y., Morishita R. Gene Ther. 9:2002;1221-1229
8. Morishita R., et al. Nat. Med. 3:1997;894-899
9. Kapsenberg M.L. Nat. Rev. Immunol. 3:2003;984-993
10. Moser M., Murphy K.M. Nat. Immunol. 1:2000;199-205
11. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. J. Exp. Med. 188:1998;2175-2180
12. Ouaaz F., Arron J., Zheng Y., Choi Y., Beg A.A. Immunity. 16:2002;257-270
13. Lin L., Spoor M.S., Gerth A.J., Brody S.L., Peng S.L. Science. 303:2004;1017-1020
14. Corn R.A., et al. J. Immunol. 171:2003;1816-1824
15. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., Narumiya S. Nat. Med. 9:2003;744-749
16. Kabashima K., et al. J. Clin. Invest. 109:2002;883-893
17. Schreiber E., Matthias P., Muller M.M., Schaffner W. Nucleic Acids Res. 17:1989;6419
18. Abeyama K., Eng W., Jester J.V., Vink A.A., Edelbaum D., Cockerell C.J., Bergstresser P.R., Takashima A. J. Clin. Invest. 105:2000;1751-1759
19. Nunokawa, Y. and Nakatsuka, T. (2000) World (PTC) WO-0005234Patent
20. Tobe M., Isobe Y., Tomizawa H., Nagasaki T., Takahashi H., Fukazawa T., Hayashi H. Bioorg. Med. Chem. 11:2003;383-391
21. Yoshimura S., Bondeson J., Brennan F.M., Foxwell B.M., Feldmann M. Scand J. Immunol. 58:2003;165-172
22. Rosette C., Karin M. Science. 274:1996;1194-1197
23. van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P., Angel P. EMBO J. 14:1995;1798-1811